Table 3.
aUse of Continuous EEG (N = 19)
| Characteristics | N (%) |
| Institutional guideline outlining indications for cEEG | |
| Yes | 6 (32) |
| No | 13 (68) |
| Indications for cEEG to evaluate for NCSs | |
| After treatment of seizures/status epilepticus without return to baseline | 18 (95) |
| NCSs or high-risk patterns on routine EEG | 18 (95) |
| Altered mental status with risk factors of NCSs | 17 (89) |
| Altered mental status of unknown etiology | 11 (58) |
| Post–cardiac arrest seizures/status epilepticus | 15 (79) |
| Indications for cEEG (other than seizure detection/monitoring) | |
| Spell characterization | 19 (100) |
| Post–cardiac arrest neuroprognostication | 9 (47) |
| Depth of anesthesia | 8 (42) |
| Delayed cerebral ischemia monitoring | 3 (16) |
| ICP monitoring | 2 (11) |
| Availability of quantitative EEG | |
| Yes | 5 (26) |
| No | 14 (74) |
Abbreviations: cEEG = continuous EEG; NCS = nonconvulsive seizure.
Institutions without cEEG excluded from analysis (n = 3).